Schellenberg Wittmer advised Abacus Medicine Group, a Danish group active in the field of modern healthcare, on the acquisition of Swiss Cardio Technologies AG. The Swiss company specializes in cardioplegia, a technique used to intentionally and temporarily interrupt cardiac activity in order to facilitate bypass surgery or other cardiac and aortic procedures.
Our team consisted of Oliver Triebold, Elia Schunck, Jonas Rahm, Filip Majernik and Nanina Lätsch (all Corporate/M&A), Lorenza Ferrari Hofer and Patrick Gürtler (both Life Sciences/IP), Roland Mathys and Noémi Ziegler (both ICT) and Petra Spring and Ruba Kassem (both Employment)